Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NYSE:OPK)

8.26
Delayed Data
As of Feb 05
 -0.18 / -2.13%
Today’s Change
7.12
Today|||52-Week Range
19.20
-17.81%
Year-to-Date

Today’s Trading

Previous close8.44
Today’s open8.44
Day’s range8.15 - 8.54
Volume3,868,337
Average volume (3 months)4,897,573
Market cap$4.5B
Dividend yield--
Data as of 4:01pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-28.12%
Earnings growth (this year)+85.77%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.60%
P/E ratioNM
Price/Sales46.27
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.03-3.13%
MDVNMedivation Inc-1.42-4.65%
ALKSAlkermes Plc-1.14-3.42%
GRFSGrifols SA+0.51+3.45%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 16, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$91.1M
Annual profit (last year)-$171.7M
Net profit margin-188.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Partner Offers